PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 114 filers reported holding PARATEK PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 2.75 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $82,190 | -84.8% | 43,952 | -60.6% | 0.00% | -100.0% |
| Q3 2021 | $542,000 | -68.4% | 111,547 | -55.7% | 0.00% | -75.0% |
| Q2 2021 | $1,716,000 | +952.8% | 251,598 | +520.9% | 0.01% | +700.0% |
| Q4 2019 | $163,000 | -81.1% | 40,522 | -15.9% | 0.00% | -97.2% |
| Q4 2017 | $862,000 | -21.6% | 48,160 | +9.5% | 0.04% | -29.4% |
| Q3 2017 | $1,100,000 | +16.8% | 43,987 | +12.1% | 0.05% | +24.4% |
| Q2 2017 | $942,000 | – | 39,238 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 2,600,410 | $16,279,000 | 2.44% |
| Abingworth LLP | 1,041,131 | $6,517,000 | 2.23% |
| Telemetry Investments, L.L.C. | 194,789 | $1,219,000 | 2.06% |
| AIGH Capital Management LLC | 749,608 | $4,692,000 | 1.91% |
| Trellus Management Company, LLC | 340,000 | $2,128,000 | 1.76% |
| Bruce & Co., Inc. | 929,312 | $5,817,000 | 1.12% |
| Worth Venture Partners, LLC | 191,093 | $1,196,000 | 0.95% |
| GENERAL AMERICAN INVESTORS CO INC | 1,000,751 | $6,265,000 | 0.62% |
| Weil Company, Inc. | 104,907 | $657,000 | 0.39% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 140,020 | $877,000 | 0.29% |